ArticleScience translational medicine2025

Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.

Beltran Borges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.